In vitro and In vivo Radiosensitization Induced by the DNA Methylating Agent TemozolomideWHOON JONG KIL; CERNA, David; BURGAN, William E et al.Clinical cancer research. 2008, Vol 14, Num 3, pp 931-938, issn 1078-0432, 8 p.Article

Temozolomide: A Safe and Effective Treatment for Malignant Digestive Endocrine TumorsMAIRE, Frédérique; HAMMEL, Pascal; RUSZNIEWSKI, Philippe et al.Neuroendocrinology (Basel). 2009, Vol 90, Num 1, pp 67-72, issn 0028-3835, 6 p.Article

Cooperative function of Chk1 and p38 pathways in activating G₂ arrest following exposure to temozolomideHIROSE, Yuichi; KATAYAMA, Makoto; BERGER, Mitchel S et al.Journal of neurosurgery. 2004, Vol 100, Num 6, pp 1060-1065, issn 0022-3085, 6 p.Article

Chemotherapy-Associated Steatohepatitis with Temozolomide and DexamethasoneMILLER, Robert J. H; XIANYONG GUI; EASAW, Jacob C et al.Canadian journal of neurological sciences. 2012, Vol 39, Num 4, pp 547-549, issn 0317-1671, 3 p.Article

Treatment of Nelson's syndrome with temozolomideMOYES, V. J; ALUSI, G; SABIN, H. I et al.European journal of endocrinology. 2009, Vol 160, Num 1, pp 115-119, issn 0804-4643, 5 p.Article

A Rare Case of Aplastic Anemia Caused by TemozolomideGEORGE, Benjamin J; EICHINGER, Jessica B; RICHARD, Thomas J et al.Southern medical journal (Birmingham, Ala. Print). 2009, Vol 102, Num 9, pp 974-976, issn 0038-4348, 3 p.Article

Temozolomide in the treatment of solid tumours: current results and rationale for dosing/schedulingPAYNE, M. J; PRATAP, S. E; MIDDLETON, M. R et al.Critical reviews in oncology/hematology. 2005, Vol 53, Num 3, pp 241-252, issn 1040-8428, 12 p.Article

The role of base excision repair in the sensitivity and resistance to temozolomide-mediated cell deathTRIVEDI, Ram N; ALMEIDA, Karen H; FORNSAGLIO, Jamie L et al.Cancer research (Baltimore). 2005, Vol 65, Num 14, pp 6394-6400, issn 0008-5472, 7 p.Article

One week on/one week off: A novel active regimen of temozolomide for recurrent glioblastomaWICK, W; STEINBACH, J. P; KÜKER, W. M et al.Neurology. 2004, Vol 62, Num 11, pp 2113-2115, issn 0028-3878, 3 p.Article

MiR-139 Inhibits Mcl-1 Expression and Potentiates TMZ-Induced Apoptosis in GliomaLI, Rui-Yan; CHEN, Ling-Chao; YANG, Dong-Bo et al.CNS neuroscience & therapeutics (Print). 2013, Vol 19, Num 7, pp 477-483, issn 1755-5930, 7 p.Article

Temozolomide-Mediated DNA Methylation in Human Myeloid Precursor Cells: Differential Involvement of Intrinsic and Extrinsic Apoptotic PathwaysHAIYAN WANG; SHANBAO CAI; SHOKOLENKOC, Inna et al.Clinical cancer research (Print). 2013, Vol 19, Num 10, pp 2699-2709, issn 1078-0432, 11 p.Article

Disseminated salmonellosis in a patient treated with temozolomideGEORGESCU, Georgiana; ISOLA, Ignatio M; YOUSSEF, Souad et al.The Journal of infection. 2008, Vol 57, Num 5, pp 414-415, issn 0163-4453, 2 p.Article

Hypoxia-inducible factor-1 inhibition in combination with temozolomide treatment exhibits robust antitumor efficacy in vivoLEIMING LI; XIAOYU LIN; SHOEMAKER, Alex R et al.Clinical cancer research. 2006, Vol 12, Num 15, pp 4747-4754, issn 1078-0432, 8 p.Article

MGMT methylation : A marker of response to temozolomide in low-grade gliomasEVERHARD, Sibille; KALOSHI, Gentian; DELATTRE, Jean-Yves et al.Annals of neurology. 2006, Vol 60, Num 6, pp 740-743, issn 0364-5134, 4 p.Article

IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomasHOUILLIER, C; WANG, X; HOANG-XUAN, K et al.Neurology. 2010, Vol 75, Num 17, pp 1560-1566, issn 0028-3878, 7 p.Article

ABT-888 Confers Broad In vivo Activity in Combination with Temozolomide in Diverse TumorsPALMA, Joann P; WANG, Yi-Chun; ZHU, Gui-Dong et al.Clinical cancer research (Print). 2009, Vol 15, Num 23, pp 7277-7290, issn 1078-0432, 14 p.Article

IDH1 mutations in low-grade astrocytomas predict survival but not response to temozolomideDUBBINK, H. J; TAAL, W; BOOGERD, W et al.Neurology. 2009, Vol 73, Num 21, pp 1792-1795, issn 0028-3878, 4 p.Article

Lentivirus-mediated expression of mutant MGMT^P140K protects human CD34⁺ cells against the combined toxicity of O⁶-benzylguanine and 1,3-bis(2-chloroethyl)-nitrosourea or temozolomideCHINNASAMY, Dhanalakshmi; FAIRBAIRN, Leslie J; NEUENFELDT, James et al.Human gene therapy. 2004, Vol 15, Num 8, pp 758-769, issn 1043-0342, 12 p.Article

A genome-wide association analysis of temozolomide response using lymphoblastoid cell lines shows a clinically relevant association with MGMTBROWN, Chad C; HAVENER, Tammy M; MEDINA, Marisa W et al.Pharmacogenetics and genomics (Print). 2012, Vol 22, Num 11, pp 796-802, issn 1744-6872, 7 p.Article

INHIBITION OF METALLOPROTEINASES DERIVED FROM TUMOURS: NEW INSIGHTS IN THE TREATMENT OF HUMAN GLIOBLASTOMAGABELLONI, P; DA POZZO, E; BENDINELLI, S et al.Neuroscience. 2010, Vol 168, Num 2, pp 514-522, issn 0306-4522, 9 p.Article

Correction: Article on nhibition of NF-κB by TemozolomideCancer research (Chicago, Ill.). 2009, Vol 69, Num 4, issn 0008-5472, p. 1695Article

Actualités sur le témozolomide (Chicago, 30 mai-3 juin 2008)ANDRE-DAVID, F.La Lettre du cancérologue (Boulogne). 2008, Vol 17, Num 7, pp 3-8, issn 1165-113X, 6 p., SUP3Article

Novel poly(ADP-ribose) polymerase-1 inhibitor, AG14361, restores sensitivity to temozolomide in Mismatch repair-deficient cellsCURTIN, Nicola J; WANG, Lan-Zhen; NEWELL, David R et al.Clinical cancer research. 2004, Vol 10, Num 3, pp 881-889, issn 1078-0432, 9 p.Article

Exogenous IGFBP-2 promotes proliferation, invasion, and chemoresistance to temozolomide in glioma cells via the integrin β1-ERK pathwayHAN, S; LI, Z; MASTER, L. M et al.British journal of cancer. 2014, Vol 111, Num 7, pp 1400-1409, issn 0007-0920, 10 p.Article

Irinotecan and temozolomide brain distribution: a focus on ABCB1GOLDWIRT, Lauriane; BECCARIA, Kevin; CARPENTIER, Alexandre et al.Cancer chemotherapy and pharmacology. 2014, Vol 74, Num 1, pp 185-193, issn 0344-5704, 9 p.Article